Cassaday & Co Wealth Management
ACAD icon

Cassaday & Co Wealth Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Cassaday & Co Wealth Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.9K Hold
840
– – ﹤0.01% 862
2026
Q2 		$21.3K Hold
840
– – ﹤0.01% 764
2026
Q1 		$18.7K Buy
+840
New +$20.1K ﹤0.01% 797

Other funds holding ACAD

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $45.4B AUM 34.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Cassaday & Co Wealth Management's ACAD Position: Q3 2026 in Review

Cassaday & Co Wealth Management held its Acadia Pharmaceuticals (ACAD) position steady in Q3 2026 at 840 shares worth $16.9K. The position accounts for ﹤0.01% of the portfolio, ranked #862.

Cassaday & Co Wealth Management first reported a position in ACAD in Q1 2026 and has held it in 3 quarters since. The position peaked at $21.3K in Q2 2026. 179 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.

  • Cassaday & Co Wealth Management held 840 shares of Acadia Pharmaceuticals worth $16.9K as of Q3 2026.
  • Cassaday & Co Wealth Management left its Acadia Pharmaceuticals share count unchanged in Q3 2026.
  • Acadia Pharmaceuticals made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q3 2026, its #862 holding.
  • Cassaday & Co Wealth Management first reported a position in Acadia Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Cassaday & Co Wealth Management's Acadia Pharmaceuticals position peaked at $21.3K in Q2 2026.
  • 179 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.